Literature DB >> 10426377

Regional postprandial fatty acid metabolism in different obesity phenotypes.

Z Guo1, D D Hensrud, C M Johnson, M D Jensen.   

Abstract

To examine if postprandial splanchnic/hepatic free fatty acid (FFA) delivery is increased in upper-body (UB) obesity, and to determine the adipose tissue depots responsible for the greater postprandial FFA availability, we measured systemic and regional uptake and release of FFAs ([1-(14)C]palmitate) before and during a 5-h frequent-feeding mixed meal in eight UB and eight lower-body (LB) obese women. Postabsorptive FFA flux and splanchnic FFA delivery were not different in UB and LB obese women; however, postprandial FFA concentrations (257 +/- 45 vs. 81 +/- 12 micromol/l, P < 0.0001), FFA flux (8.5 +/- 1.2 vs. 3.9 +/- 0.8 micromol x kg(-1) fat-free mass x min(-1), P < 0.0001), splanchnic FFA delivery (275 +/- 45 vs. 88 +/- 24 micromol/min, respectively, P < 0.005), and estimated hepatic FFA delivery were greater in UB than LB obese women. Nonsplanchnic UB adipose tissue FFA release was greater in UB than in LB obese women (276 +/- 71 vs. 97 +/- 37 micromol/min, respectively, P < 0.05) and accounted for the greater postprandial FFA availability in UB obesity. Postprandial leg glucose uptake was less in UB than in LB obese women (8.4 +/- 5.1 vs. 22.9 +/- 2.6 micromol x kg(-1) leg fat-free mass x min(-1), P < 0.05). We conclude that the elevated postprandial FFA release observed in UB obese women originates from the nonsplanchnic UB fat, not visceral fat. These results suggest that visceral fat may be a marker for, but not the source of, excess postprandial FFAs in obesity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426377     DOI: 10.2337/diabetes.48.8.1586

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  59 in total

1.  Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.

Authors:  Sarah R Preis; Joseph M Massaro; Sander J Robins; Udo Hoffmann; Ramachandran S Vasan; Thomas Irlbeck; James B Meigs; Patrice Sutherland; Ralph B D'Agostino; Christopher J O'Donnell; Caroline S Fox
Journal:  Obesity (Silver Spring)       Date:  2010-03-25       Impact factor: 5.002

2.  The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.

Authors:  G D Tan; B A Fielding; J M Currie; S M Humphreys; M Désage; K N Frayn; M Laville; H Vidal; F Karpe
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

3.  Pioglitazone increases non-esterified fatty acid clearance in upper body obesity.

Authors:  S Shadid; M D Jensen
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

4.  The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.

Authors:  G D Tan; M J Neville; E Liverani; S M Humphreys; J M Currie; L Dennis; B A Fielding; F Karpe
Journal:  Diabetologia       Date:  2005-12-17       Impact factor: 10.122

5.  Very-long-chain ω-3 fatty acid supplements and adipose tissue functions: a randomized controlled trial.

Authors:  Kazanna C Hames; Maria Morgan-Bathke; Debra A Harteneck; Lendia Zhou; John D Port; Ian R Lanza; Michael D Jensen
Journal:  Am J Clin Nutr       Date:  2017-04-19       Impact factor: 7.045

6.  Lean NAFLD: An Underrecognized Outlier.

Authors:  Julia Wattacheril; Arun J Sanyal
Journal:  Curr Hepatol Rep       Date:  2016-04-14

Review 7.  Mechanisms and metabolic implications of regional differences among fat depots.

Authors:  Tamara Tchkonia; Thomas Thomou; Yi Zhu; Iordanes Karagiannides; Charalabos Pothoulakis; Michael D Jensen; James L Kirkland
Journal:  Cell Metab       Date:  2013-04-11       Impact factor: 27.287

Review 8.  Role of body fat distribution and the metabolic complications of obesity.

Authors:  Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

9.  Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects.

Authors:  François Normand-Lauzière; Frédérique Frisch; Sébastien M Labbé; Patrick Bherer; René Gagnon; Stephen C Cunnane; André C Carpentier
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

10.  Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type.

Authors:  Yoshinori Miyazaki; Ralph A DeFronzo
Journal:  Cardiovasc Diabetol       Date:  2009-08-05       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.